Daigo Matsui

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Lenvatinib Might Induce Activation of Host Immunity in Patients with Hepatocellular Carcinoma.

Lenvatinib Might Induce Activation of Host Immunity in Patients with Hepatocellular Carcinoma.

Journal: Oncology

Published: July 29, 2022

Adaptation of lenvatinib treatment in patients with hepatocellular carcinoma and portal vein tumor thrombosis.

Adaptation of lenvatinib treatment in patients with hepatocellular carcinoma and portal vein tumor thrombosis.

Journal: Cancer chemotherapy and pharmacology

Published: May 19, 2021

Tivantinib Decreases Hepatocyte Growth Factor-Induced BCRP Expression in Hepatocellular Carcinoma HepG2 Cells.

Tivantinib Decreases Hepatocyte Growth Factor-Induced BCRP Expression in Hepatocellular Carcinoma HepG2 Cells.

Journal: Biological & pharmaceutical bulletin

Published: September 04, 2020

Influence of Sorafenib on Host Immunity in Patients with Liver Cirrhosis With Advanced Hepatocellular Carcinoma Stratified by Etiology.

Influence of Sorafenib on Host Immunity in Patients with Liver Cirrhosis With Advanced Hepatocellular Carcinoma Stratified by Etiology.

Journal: Anticancer research

Published: February 08, 2019

Flash Imaging Used in the Post-vascular Phase of Contrast-Enhanced Ultrasonography is Useful for Assessing the Progression in Patients with Hepatitis C Virus-Related Liver Disease.

Flash Imaging Used in the Post-vascular Phase of Contrast-Enhanced Ultrasonography is Useful for Assessing the Progression in Patients with Hepatitis C Virus-Related Liver Disease.

Journal: Ultrasound in medicine & biology

Published: April 20, 2018

Hepatic arterialization can predict the development of collateral veins in patients with HCV-related liver disease.

Hepatic arterialization can predict the development of collateral veins in patients with HCV-related liver disease.

Journal: Journal of ultrasound

Published: April 20, 2018

Effect of Hepatic Inflammation in Chronic Hepatitis C Infection on Fibrosis Assessment by Arrival Time Parametric Imaging.

Effect of Hepatic Inflammation in Chronic Hepatitis C Infection on Fibrosis Assessment by Arrival Time Parametric Imaging.

Journal: Ultrasound quarterly

Published: April 11, 2018

Sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus.

Sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus.

Journal: Anticancer research

Published: April 12, 2015

VEGF in patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy.

VEGF in patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy.

Journal: Anticancer research

Published: April 12, 2015

The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy.

The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy.

Journal: Clinical cancer drugs

Published: December 24, 2014

Host Immunity Influences the Efficacy of Combined Intra-Arterial Chemotherapy for Advanced Hepatocellular Carcinoma in Liver Cirrhosis Patients.

Host Immunity Influences the Efficacy of Combined Intra-Arterial Chemotherapy for Advanced Hepatocellular Carcinoma in Liver Cirrhosis Patients.

Journal: Hepato-gastroenterology

Published: May 01, 2014

A case of solitary bile duct hamartoma with advanced gastric carcinoma: findings in contrast-enhanced ultrasonography.

A case of solitary bile duct hamartoma with advanced gastric carcinoma: findings in contrast-enhanced ultrasonography.

Journal: Journal of medical ultrasonics (2001)

Published: May 09, 2013

Showing 1-12 of 16

Last Updated: 09/26/2026